Matches in Nanopublications for { ?s ?p "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP196075.RAotNrqja-p6Rs25Wqel5p0OGmkc1eNRF7kWf4dAbtxcM130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP196075.RAotNrqja-p6Rs25Wqel5p0OGmkc1eNRF7kWf4dAbtxcM130_provenance.
- NP599886.RA4PzS3Xbh7WFwEnSQ6SqJVadNpQZHdRIvERu3Ym-lfwA130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599886.RA4PzS3Xbh7WFwEnSQ6SqJVadNpQZHdRIvERu3Ym-lfwA130_provenance.
- assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP429538.RA0WpKh0Y2vHS60uEmERF6WMDg5MKfgKQbOUZFw-scspg130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429538.RA0WpKh0Y2vHS60uEmERF6WMDg5MKfgKQbOUZFw-scspg130_provenance.
- NP429552.RAMZkywve4Al0d36GGaqRbw_c8D5xMDZkYRvmsOBwVGso130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429552.RAMZkywve4Al0d36GGaqRbw_c8D5xMDZkYRvmsOBwVGso130_provenance.
- NP1033226.RAPqzKflQRogZ61HXX5tXwHLzdptsATvRRn_jKPrGEEdg130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033226.RAPqzKflQRogZ61HXX5tXwHLzdptsATvRRn_jKPrGEEdg130_provenance.
- NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_assertion description "[Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033225.RAxv3JOvKP2dzzFTjMCWAGhcYUn7nHMbL5M-V3LlzHEKU130_provenance.